Abstract
Antiphospholipid syndrome is a systemic autoimmune disease with unclear etiology and complex pathogenesis. It can be a single nosological unit or in the context of another systemic disease of the connective tissue – most commonly systemic lupus erythematosus (SLE). The presence of antiphospholipid antibodies in pregnant women is associated with an increased rate of complications during pregnancy. The most common symptoms are preeclampsia and eclampsia, early spontaneous abortions and late fetal loss, in the absence or presence of a proven genetic defect for congenital thrombophilia and/or chromosomal diseases. A multidisciplinary approach and regular patient consultations are key factors in the follow-up and positive outcomes of pregnancy in women with SLE and antiphospholipid syndrome (APS). Timely treatment with corticosteroids, anticoagulants, antiаggregant agents, and intravenous immunoglobulins repeatedly increases the chance of successful completion of pregnancy with live birth.
Publisher
Bulgarian Rheumatology Society
Reference15 articles.
1. Stoilov N, Rashkov R, Stoilov R. Antiphospholipid syndrome – historical data, etiology and pathogenesis. Revmatologiia. 2011;19(4);26-33.
2. Stoilov N, Zdravkova Ya, Rashkov R. Antiphospholipid syndrome – antibodies and clinico-immunological correlations. Revmatologiia. 2013;2(1);20-30.
3. Chamley LW, McKay EJ, Pattison NS. Inhibition of heparin/ antithrombin III cofactor activity by anticardiolipin antibodies: A mechanism for thrombosis. Thromb. Res. 1993;71;103-111.
4. Rashkov R, Yoneva Ts, Zdravkova Ya et al. Clinical and immunological characteristics of systemic lupus erythematosus and their relation to disease activity – data of the Bulgarian SLE registry. Revmatologiia 2014;22(3-4);25-37.
5. Ames PR, Tommasino C, D‘Andrea G et al. Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies prevalence and significance. Thromb Haemost. 1998;79: 46-49.